Cynthia Aniegbuna Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 16930 Iver Ironwood Trl, Richmond, TX 77407 Phone: 908-275-7288 |
Anuli Josephine Ezumah Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 2122 Ridgeworth Ln, Richmond, TX 77469 Phone: 713-371-6089 Fax: 281-232-2757 |
Dr. Jacquelyn T Williams, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 4606 Redbird Ln, Richmond, TX 77406 Phone: 805-907-2778 Fax: 805-496-6862 |
Adam Scott Dziedzic, MA, Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 22001 Southwest Fwy Ste 200, Richmond, TX 77469 Phone: 832-595-7700 |
Connie S Veazey, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 21903 Venture Park Dr, Richmond, TX 77406 Phone: 832-595-4641 |
Jazmine Nash Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 6550 White Tail Ct, Richmond, TX 77406 Phone: 708-890-7956 |
Dr. Roger Brent Worthen, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 711 S 11th St, Richmond, TX 77469 Phone: 281-342-0090 Fax: 281-341-9388 |
Marissa Kepple, MA, LPA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 23035 S Waterlily Dr, Richmond, TX 77406 Phone: 817-368-9386 |
News Archive
The immune system appears to put a premium on maintaining lung function in infants infected with the influenza virus by mounting a rapid response to repair damaged cells, according to research led by St. Jude Children's Research Hospital. The findings appear today in the scientific journal Immunity.
MedWaves' AveCure microwave coagulation-ablation (MWA) system uses microwave energy to volumetrically coagulate-ablate (destroy) soft-tissue lesions safely, effectively, precisely and with repeatability.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced three new contracts to fund research on vaccines to protect against emerging infectious diseases and biological threats that could be used in a terror attack. Each project focuses on simple and efficient vaccine delivery approaches that could be deployed quickly. The total funding for the three contracts could reach $68 million, depending on the successful completion of defined project milestones.
Professor Dame Sally Davies, the UK's Chief Medical Officer is warning that the world must do more to prevent the spread of infectious diseases.
› Verified 8 days ago